- Home
- BCRX vs BUSE Comparison
BCRX vs BUSE Comparison
Compare BCRX & BUSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCRX | BUSE |
|---|---|---|
| Founded | 1986 | 1868 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 1995 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BCRX | BUSE |
|---|---|---|
| Price | $8.51 | $24.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | $20.82 | ★ $27.00 |
| AVG Volume (30 Days) | ★ 4.2M | 520.0K |
| Earning Date | 05-15-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 4.15% |
| EPS Growth | ★ 381.40 | N/A |
| EPS | 1.21 | ★ 1.47 |
| Revenue | $25,186,000.00 | ★ $719,584,000.00 |
| Revenue This Year | N/A | $23.61 |
| Revenue Next Year | $12.55 | $3.69 |
| P/E Ratio | ★ $7.23 | $17.05 |
| Revenue Growth | N/A | ★ 55.66 |
| 52 Week Low | $6.00 | $18.40 |
| 52 Week High | $11.31 | $27.65 |
Technical Indicators
Market Signals| Indicator | BCRX | BUSE |
|---|---|---|
| Relative Strength Index (RSI) | 63.78 | 39.49 |
| Support Level | $7.95 | $23.53 |
| Resistance Level | $8.68 | $25.14 |
| Average True Range (ATR) | 0.31 | 0.76 |
| MACD | 0.05 | -0.17 |
| Stochastic Oscillator | 70.43 | 21.26 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech and Wealth Management. The banking segment generates a vast majority of its revenue.